Home›Companies›Biotech & Pharma›Aqur Biosciences

Aqur Biosciences, Inc.

Develops a cholesterol treatment candidate for people at risk of cardiovascular disease.

Updated Nov 9, 2026·Latest SEC filing Sep 18, 2026·Suggest an edit

About Aqur Biosciences

Aqur Biosciences is a private company based in Westlake Village, California. It has reported $1,500,000 raised in one offering on Form D since September 2026. Its chief executive is Michael Fole.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 3, 2026Sep 18, 2026$1,500,000fully sold7$214KEquity, Options, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Aqur Biosciences's Form D filed Sep 18, 2026.

Michel Denarie
Michel Denarie
Chief Operating Officer
Jeffrey Wolin
Jeffrey Wolin
President and director
Tomi Sawyer
Tomi Sawyer
Chief Scientist & Advisor
Michael Fole
Michael Fole
Chief Executive Officer
James Leach
James Leach
Chief Financial Officer

Sources

  1. SECAqur Biosciences, Inc. filing history
  2. CompanyTerms of use
  3. CompanyTeam